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Abstract
Background: A rapid decrease of serum potassium concentrations during haemodialysis produces a significant
increase in blood pressure parameters at the end of the session, even if effects on intra-dialysis pressure are not
seen. Paradoxically, in animal models potassium is a vasodilator and decreases myocardial contractility. The purpose
of this trial is to study the precise haemodynamic consequences induced by acute changes in potassium
concentration during haemodialysis.
Methods: In 24 patients, 288 dialysis sessions, using a randomised single blind crossover design, we compared six
dialysate sequences with different potassium profiles. The dialysis sessions were divided into 3 tertiles, casually
modulating potassium concentration in the dialysate between the value normally used K and the two cut-off
points K+1 and K-1 mmol/l. Haemodynamics were evaluated in a non-invasive manner using a finger beat-to-beat
monitor.
Results: Comparing K-1 and K+1, differences were found within the tertiles regarding systolic (+5.3, +6.6, +2.3
mmHg, p < 0.05, < 0.05, ns) and mean blood pressure (+4.3, +6.4, -0.5 mmHg, p < 0.01, < 0.01, ns), as well as
peripheral resistance (+212, +253, -4 dyne.sec.cm-5, p < 0.05, < 0.05, ns). The stroke volume showed a non-
statistically-significant inverse trend (-3.1, -5.2, -0.2 ml). 18 hypotension episodes were recorded during the course
of the study. 72% with K-1, 11% with K and 17% with K+1 (p < 0.01 for comparison K-1 vs. K and K-1 vs. K+1).
Conclusions: A rapid decrease in the concentration of serum potassium during the initial stage of the dialysis-
obtained by reducing the concentration of potassium in the dialysate-translated into a decrease of systolic and
mean blood pressure mediated by a decrease in peripheral resistance. The risk of intra-dialysis hypotension
inversely correlates to the potassium concentration in the dialysate.
Trial Registration Number: NCT01224314
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Background
Kidneys are responsible for long-term potassium home-
ostasis; this exposes patients with end-stage renal disease
to a high risk of hyperkalaemia [1-5]. Recovering potas-
sium homeostasis is one of the important objective of
dialysis. Considering that its location is mainly intracellu-
lar (98% of the pool [1]), its potential removability during
a haemodialysis session is quantitatively modest (between
40 and 80 mmol corresponding to 1-2% of total body
potassium) [6]. As a consequence, even if, in order to be
suitable, potassium removal during dialysis should be
equal to the amount accumulated during the inter-dialy-
tic phase, in clinical practice the potassium concentration
in the dialysate is usually adjusted with the suboptimal
goal of avoiding pre-dialysis hyperkalaemia [7].
The importance of the body content and serum con-
centration of potassium to control blood pressure
remains controversial. Epidemiological data suggest a
role for potassium depletion as a co-factor in the devel-
opment and severity of hypertension, while dietary
potassium inversely correlates with blood pressure
[8-10]. In animal models, an acute decrease in serum
potassium concentration produces vasocostriction
mediated by the vascular endothelium and an increase
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in myocardial contractility; the opposite effect is
observed if it increases [11,13].
In haemodialysis nephrologists are faced with sudden
changes in blood pressure and haemodynamic fragility
phases that have a multi-factorial origin; ultrafiltration,
decrease in osmolarity with imbalance and correction of
metabolic acidosis play a predominant role [7,14-19].
Despite this, and thanks to some strategies based on
current practice, with particular reference to calcium
and magnesium concentration in the dialysate [16,20],
dialysate temperature [21] and ultrafiltration and sodium
concentration profiles [7,22-25], pressure stability is
guaranteed as a general rule. Some electrolytes, particu-
larly sodium and bicarbonate, can be modulated in pro-
files with the purpose of better respecting the gap in
osmolarity or concentration that is established during
the haemodialysis session, but their haemodynamic
effect still remains controversial [21,23,25].
Serum potassium is an electrolyte whose concentra-
tion - in order to guarantee a negative balance - varies
rapidly and significantly during dialysis, frequently
resulting in going from pre-dialysis hyperpotassaemia to
intra-dialysis hypopotassaemia. In a study performed by
Dolson, designed to analyze the consequences of acute
potassium changes on haemodynamics, differences in
intra-dialytic blood pressure were not found between
the groups treated with dialysates containing 1, 2 or 3
mmol/l of potassium [6]. However, at the end of the
dialysis session those patients treated with the lower
potassium concentrations showed what was called a
“rebound hypertension” [6].
With the purpose of better characterising this phe-
nomenon, we redesigned the study dividing the dialysis
session into 3 phases (in fact, clinical practice suggests
that the haemodynamic pattern at the beginning, inter-
mediate and final phases of the dialysis are not the
same) and programming for each a more or less sharp
drop in serum potassium concentration, respecting in
the meantime the need to remove the amount of potas-
sium that usually keeps the patient in steady-state.
Using a crossover protocol, we divided the dialysis ses-
sion into 3 tertiles where the potassium concentration
in the dialysate was modulated between the usual con-
centration for the study subject and two cut-off points
at +1 e -1 mmol/l respectively. To complete the infor-
mation provided by blood pressure, haemodynamics
were measured in a non-invasive manner using a finger
beat-to-beat monitor.
The primary end point was the difference in haemody-
namic parameters between the extremes in potassium
concentration of the dialysate, while the incidence of
hypotension during dialysis was considered a secondary
end point.
Methods
Twenty-four chronic haemodialysis patients (13 male
and 11 female) were enrolled in the study. Each patient
was dialysed for 3 to 4 hours and 30 minutes three
times a week and was clinically stable and without inter-
current illnesses. Using a single blind crossover design,
patients were randomised in the six dialysate potassium
sequences of the study. Each dialysis session was divided
into three equal parts (tertiles): during one part the
potassium concentration of the dialysate was the same
as the one usually prescribed to the patient, whereas
during the other two parts it was either increased or
reduced by 1 mmol/L. The 6 different permutations
were repeated twice, so that each patient underwent 12
dialysis sessions during the study (see Table 1 for
sequence details).
The haemodialyses were performed using a 4008 H
machine, equipped with a cartridge of bicarbonate
Bibag©, and a high flux single use polysulfone mem-
brane, all from Fresenius Medical Care (Bad Homburg,
Germany). The prescribed dialyser effective surface area,
dialysis fluid conductibility, dialysate temperature and
composition (with the exception of potassium concen-
tration), effective blood flow, and dry weight were
recorded at the enrolment in the study and were then
left unchanged. The medications of the patients were
also left unchanged. Serum potassium and patient
weight were measured at the beginning and at the end
of each dialysis session. Blood samples were taken from
the arterial limb of the shunt.
Kt/V was used to quantify haemodialysis adequacy and
was calculated using a second generation single-pool
Daugirdas formula (Kt/V = -ln(R-0.03) + [(4-3.5 × R) ×
(UF/W)], where R = post-dialysis BUN/pre-dialysis
BUN, UF = net ultrafiltration, W = weight, K = dialyzer
clearance of urea, t = dialysis time, and V = patient’s
total body water.
The incidence of hypotension episodes (defined as a
systolic blood pressure <90 mmHg) was recorded.
Table 1 Dialysate potassium sequences
Sequence Dialysate Potassium
1st tertile 2nd tertile 3th tertile
1 K-1 K K+1
2 K-1 K+1 K
3 K K-1 K+1
4 K K+1 K-1
5 K+1 K K-1
6 K+1 K-1 K
Dialysate potassium sequences used in the study. The population was
randomised to begin with one of the six sequences. (K = usual potassium
concentration (range 2 to 4 mmol/l), K+1 and K-1 = + or -1 mmol/L of
potassium).
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Systolic and diastolic blood pressures, heart rate,
stroke volumes (integrated mean of the flow waveform
between the current upstroke and the dicrotic notch)
and total peripheral resistances (ratio of mean arterial
pressure to stroke volume multiplied by heart rate) were
evaluated at the beginning of the session and then every
30 minutes using a Finometer© finger beat-to-beat
monitor (Finapres Medical Systems BV, Arnhem, The
Netherlands). Finometer© measures finger blood pres-
sure noninvasively on a beat-to-beat basis and gives
waveform measurements similar to intra-arterial
recordings.
Mean blood pressure (BPmean) was calculated using
the following formula: BPmean = (BPsyst+2BPdias)/3,
where BPsyst and BPdias are systolic and diastolic blood
pressure, respectively.
The fluid loss as a function of the time was considered
to be constant during the dialysis session and was
recorded as total ultrafiltration. The dry weight was
established on the basis of clinical assessment and
bioimpedance (Body Composition Monitor, Fresenius
Medical Care; Bad Homburg, Germany).
Statistical analyses were performed using the SAS Sys-
tem (Statistical Analysis System). Comparisons between
body weight, potassium concentration and haemody-
namic parameters were done first with an ANOVA fol-
lowed, if significant by a paired t-test performed
between the mean values obtained in each patient with
each modality. To improve the probability of showing
significant differences, the haemodynamic parameters
within the tertiles were compared against the dialysate
potassium concentration cut-off points (-1 vs. +1 mmol/
l). Percentages were compared using a Fisher Exact test.
In all cases, a P ≤ 0.05 was considered statistically signif-
icant; P was expressed as ns (not significant) or as sig-
nificant (P ≤ 0.05).
The protocol of the study was approved by the local
Ethical Committee (Comitato Etico Cantonale del Can-
tone Ticino). All the patients gave written informed
consent prior to enrolling in the study.
Results
Characteristics of the studied population
The characteristics of the studied population (n = 24) at
the moment of enrolment were (mean ± SD): age 70.3 ±
9.8 years, weight 71.8 ± 17.2 kg, male/female ratio 1.18.
The basis haemodialyses prescriptions were: dialyser
effective surface area 1.79 ± 0.09 m2; Kt/V 1.65 ± 0.33;
dialysis fluid conductibility 13.8 ms/cm; dialysis fluid
temperature 35.5 to 37.5°C; effective blood flow 334 ±
69 ml/min; dialysis fluid flow rate 500 to 800 ml/min,
potassium 2 to 4 mmol/l, magnesium 0.5 mml/l, cal-
cium 1.25 to 1.50 mmol/l, acetate 3 mmol/l and glucose
1 g/l (see Table 2 for details including underlying
nephropathies, comorbidities, antihypertensive drugs in
use, dry weight, dialyser surface area, dialysate duration,
and Kt/V).
Serum potassium and ultrafiltration
The average total ultrafiltration obtained in the 6
sequences of dialysate potassium concentration used for
the study did not show any significant differences. Pre-
dialysis serum potassium was in turn comparable, while,
as expected, post-dialysis serum potassium was influ-
enced mainly by the potassium concentration in the dia-
lysate during the last dialysis tertile, producing
significant differences (p < 0.01) between the sequences
that ended with the usual dialysate potassium concen-
tration, supplemented by 1 or reduced by 1 mmol/l
(Table 3).
Effect of the potassium variations on systemic
haemodynamics
The analysis of the evolution of haemodynamic para-
meters as a function of dialysis tertiles has not shown
any significant differences between the 6 dialysate
sequences used during the study (Figures 1, 2, 3 and 4).
If, however, (in post hoc analysis) the mean pressure
of the different sequences is taken into account and
grouped as a function of dialysate potassium concentra-
tion in the first tertile (1 with 2, 3 with 4 and 5 with 6),
the differences become significant (p < 0.01). The lowest
mean pressure is thus recorded in the sequences that
start by inducing the fastest decrease in serum potas-
sium (Table 4).
At the same time, by comparing - as prespecified -
haemodynamic parameters in the treatments performed
with the higher and lower potassium concentration in
the dialysate, significant differences in systolic and mean
blood pressure and peripheral resistance were found
within the tertiles. The systolic and mean blood pres-
sure, as well as peripheral resistance, were lower for the
first and second tertiles using the dialysate with the low-
est potassium concentration. The stroke volume showed
a non-statistically-significant inverse trend. In the last
tertile the differences were narrowed, losing significance
(see Figure 5, 6, 7 and 8 for details).
Incidence of hypotension episodes
Hypotension episodes were significantly more numerous
in the haemodialysis phases where the lower potassium
concentrations were used in the dialysate (Figure 9).
During the 288 dialysis performed in the study, 18
hypotension episodes (systolic blood pressure <90
mmHg) were recorded, 72% of which occurred in the
tertiles with the lower dialysate potassium concentration
(11% with the usual concentration and 17% with the
higher concentration).
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Table 2 Characteristics of the cohort
Patient
number
Sex
M/F
Age
(y)
Underlying
nephropathy
Comorbidities Medication Dry
weight
(kg)
Dialyser surface
area(m2)
Dialysis
Duration (h)
Kt/
V
Ischemic cardio-
myopathy
Diabetes
mellitus
Beta-
blockers
Calcium
antagonists
Alpha-
blockers
ACE-inhibitors
or ARB
1 F 75 Diabetic nephropathy Y Y Y N Y Y 72.5 1.8 3.0 1.51
2 F 88 Diabetic nephropathy N Y Y Y Y Y 60.0 1.8 3.0 1.48
3 M 59 Diabetic nephropathy Y Y Y N N Y 100.5 1.8 4.0 1.44
4 M 71 Nephroangiosclerosis Y N Y N N Y 69.5 1.8 4.0 1.66
5 M 59 Focal segmental
glomerulosclerosis
N N Y Y Y N 79.5 1.8 3.5 1.46
6 M 88 Nephroangiosclerosis N N Y N N N 76.0 1.4 4.0 1.52
7 F 86 Nephroangiosclerosis Y N Y N N Y 43.0 1.8 3.0 1.59
8 M 81 Nephroangiosclerosis N N Y Y N N 79.0 1.8 3.5 1.38
9 F 74 Diabetic nephropathy N Y N Y N N 81.0 1.8 3.5 1.76
10 M 64 Nephroangiosclerosis N N Y N N N 98.0 1.8 3.5 1.41
11 M 74 Nephroangiosclerosis N N N N N N 69.5 1.8 4.0 1.52
12 F 66 Trombotic
microangiopathy
N N N Y N Y 52.0 1.8 3.5 1.90
13 M 65 Focal segmental
glomerulosclerosis
N N Y N N N 87.2 1.8 4.0 2.08
14 M 72 Nephroangiosclerosis Y N N N N Y 92.0 1.8 3.0 1.00
15 F 75 Diabetic nephropathy N Y Y Y Y Y 48.0 1.8 3.5 1.56
16 M 77 Proliferative
glomerulonephritis
Y N Y N N Y 80.5 1.8 3.0 1.07
17 M 72 Diabetic nephropathy Y Y N N N Y 89.5 1.8 4.0 1.37
18 F 65 Diabetic nephropathy Y Y Y Y Y Y 48.0 1.8 3.5 2.08
19 F 56 Nephroangiosclerosis N N Y Y N Y 65.0 1.8 3.5 2.07
20 F 48 IgA nephropathy N Y Y N N N 60.0 1.8 3.5 2.20
21 F 70 Nephroangiosclerosis N N N Y N Y 47.5 1.8 3.5 2.00
22 F 64 Relapsing
pyelonephritis
N N Y Y Y Y 55.0 1.8 3.3 2.22
23 M 68 IgA nephropathy Y N N Y N N 94.5 1.8 4.0 1.52
24 M 71 Nephroangiosclerosis Y Y Y N N N 75.5 1.8 4.5 1.70
Characteristics of the population at the beginning of the study. (M, male; F, female; Y, yes; N, no; ACE, angiotensin converting enzyme; ARB, angiotensin receptor antagonists).
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Discussion
The study showed that a low potassium concentration
in the dialysate, inducing a rapid decrease in serum
potassium, causes a decrease in systolic and mean blood
pressure correlated with a decrease in peripheral resis-
tance. The decrease in pressure recorded when a dialy-
sate with a potassium concentration 1 mmol/l lower
than the one usually employed for the patient was used,
translated into a higher incidence of hypotension,
defined as episodes with systolic blood pressure <90
mmHg (72% of the episodes happened during the tertile
using the lowest dialysate potassium concentration). The
dialysate potassium concentration in the initial tertile
affects mean blood pressure for the whole dialysis ses-
sion in that a larger gap between serum and dialysate
potassium concentrations results in a lower pressure.
The effect of removing potassium is progressively
reduced during dialysis, with haemodynamic conse-
quences that are no longer significant during the final
tertile. The lesser impact during the intermediate and
final stages of dialysis could be due to the gap between
serum and dialysate potassium, which progressively nar-
rows during the dialysis session.
The data obtained agree with what was observed by
Dolson [6] who, while not highlighting pressure discre-
pancies during the dialysis using dialysates with potas-
sium concentrations of 1, 2 or 3 mmol/l, had observed
hypertension, defined as “reflex” (or “rebound”), at the
end of the session that used the two lower potassium
concentrations. The lack of differences during dialysis in
the aforementioned study could have been a consequence
of (i) the lower statistical power (11 versus 24 subjects
investigated) and (ii) the different method used (based on
the steady state prescription, we randomly reduced and
increased the dialysate potassium concentration in the
Figure 1 Systolic blood pressure. Systolic blood pressure as a
function of the dialysis tertiles in the 6 dialysate sequences (1 to 6).
Figure 2 Mean blood pressure . Mean blood pressure as a
function of the dialysis tertiles in the 6 dialysate sequences (1 to 6).
Table 3 Serum potassium and ultrafiltration
Sequence Ultrafiltration
(L)
SD Serum K pre-dialysis
(mmol/L)
SD Serum K post-
dialysis
(mmol/L)
SD pre-post dialysis
delta K
(mmol/L)
SD
1 1.68 0.99 4.65 0.77 3.90 0.32 0.83 1.02
2 1.61 0.94 4.77 0.66 3.74 0.46 1.03 0.85
3 1.54 0.95 4.92 0.71 3.93 0.32 1.05 1.02
4 1.64 0.94 4.84 0.84 3.46 0.34 1.38 0.95
5 1.51 0.82 4.74 0.69 3.39 0.51 1.31 1.58
6 1.64 1.08 4.81 0.70 3.73 0.34 1.11 0.84
Serum Potassium pre- and post-dialysis and mean total ultrafiltration as a function of the dialysate sequences. Between the pairs of sequences 1 and 3, 2 and 6
and 4 and 5, the difference in the mean post-dialysis serum potassium concentration was significant (p < 0.01).
Figure 3 Peripheral resistance. Total peripheral resistance as a
function of the dialysis tertiles in the 6 dialysate sequences (1 to 6).
Figure 4 Stroke volume. Stroke volume as a function of the
dialysis tertiles in the 6 dialysate sequences (1 to 6).
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whole group). The cited blood pressure rebound after
dialysis suggests a counterregulatory phenomenon com-
patible with an undetected intradialytic hypotension/
hypoperfusion phase.
However, if we take into account the experimental
data obtained from animals besides the typical metabolic
circumstances of kidney failure that requires dialysis, it
is surprising to observe the haemodynamic pattern that
is traced and which, contrary to expectations, shows a
hypertensive effect for acute decrease in serum potas-
sium. In fact, the experimental hypokalaemia model
demonstrates a vasoconstriction and an increase in myo-
cardial contractility [11-13]. The difference between the
theoretical and the observed pattern could be due to the
method employed to evaluate peripheral resistance
(indirect, non-invasive measurements using beat-to-beat
in our case) and the metabolic circumstances of dialysis
with sharp variations in other factors that together can
modify haemodynamics (calcaemia, osmolarity, acid-base
balance, temperature), as well as concomitant counterre-
gulatory phenomena, particularly the sympathetic and
renin-angiotensin systems. The fact that hypokalaemia
sensitizes myocardium to hypoxic related dysfunction
[26] together with the selection for the study of an
elderly population (mean age 70.3 years) with a high
incidence of ischemic cardiomyopathy (10 out of 24
subjects) could have influenced the incidence of intra-
dialytic hypotensions and the results. Moreover two
other reasons could potentially explain a blood pressure
reduction related to acute potassium decrease in the
dialysis population: hypokalaemia may exacerbate auto-
nomic dysfunction while intra-dialytic potassium loss
accounts for a decrease in total osmoles [7].
Regardless of the pathophysiological explanations of
the haemodynamic consequences, the results are poten-
tially relevant in that (i) dialysate potassium concentra-
tion could theoretically be modulable in a profile, as
proposed for other electrolytes like sodium and bicarbo-
nate and (ii) more attention could be paid to controlling
the potassium balance with alternative measures (diet,
chelating agents, avoidance of medications which inhi-
bits the renin-angiotensin system if unnecessary [27]
and possibly prescription of mineralocorticoids [28]).
Conclusions
In conclusion, a rapid decrease in the concentration of
serum potassium during the initial stage of the dialysis -
obtained by reducing the concentration of potassium in
the dialysate - translates into a decrease of systolic and
mean blood pressure mediated by a decrease in periph-
eral resistance. The risk of intra-dialysis hypotension
inversely correlates to the potassium concentration in
Table 4 Mean haemodynamic parameters
Sequence Systolic BP
(mmHg)
SD
(mmHg)
Mean BP
(mmHg)
SD
(mmHg)
TPR
(dyne.sec.cm-5)
SD
(dyne.sec.cm-5)
Stroke volume
(mL)
SD
(mL)
1 129.1 19.9 95.4 12.7 2249 898 62.9 23.0
2 135.8 18.0 98.5 10.5 2262 1143 67.5 26.5
3 137.0 20.6 98.6 13.6 2160 1134 69.0 23.4
4 137.1 19.2 101.5 12.2 2221 1010 67.9 24.3
5 137.7 21.2 99.9 12.5 2366 905 64.4 21.0
6 140.5 16.4 102.3 12.0 2277 1202 68.7 28.2
Mean values of systolic and mean blood pressure (BP), total peripheral resistance (TPR) and stroke volume for the 3 dialysis tertiles.
Figure 6 Mean blood pressure . Mean blood pressure as a
function of dialysis tertiles comparing treatments with the two
potassium (K) concentration cut-off points in the dialysate (high = K
+1 and low = K-1). P for the 1st, 2nd and 3rd tertiles: < 0.01, < 0.01
and ns respectively.
Figure 5 Systolic blood pressure. Systolic blood pressure as a
function of dialysis tertiles comparing treatments with the two
potassium (K) concentration cut-off points in the dialysate (high = K
+1 and low = K-1). P for the 1st, 2nd and 3rd tertiles: < 0.05, < 0.05
and ns respectively.
Gabutti et al. BMC Nephrology 2011, 12:14
http://www.biomedcentral.com/1471-2369/12/14
Page 6 of 8
the dialysate. Based on the results obtained by this
study, modulating potassium concentration in the dialy-
sate during haemodyalisis sessions could have favourable
haemodynamic consequences.
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